Page last updated: 2024-08-23

nitazoxanide and Neoplasms

nitazoxanide has been researched along with Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Akiyoshi, S; Hirose, L; Iwata, M; Kohara, H; Liao, J; Sawada, R; Tani, K; Yamanishi, Y1
Ahmadvand, H; Hemmati-Dinarvand, M; Seghatoleslam, A1
Alipourfard, I; Beyrami Aghbash, E; Hemmati-Dinarvand, M; Kheirandish, S; Khodadadian, A; Mokhtari, H; Seghatoleslam, A1
Chen, C; Gao, Y; Guan, Z; Li, M; Liu, Y; Pan, X; Qiu, S; Ruan, G; Wang, H; Yuan, Y; Zeng, W; Zhang, H; Zhou, L; Zhu, Q1
Bayoumi, NA; Darwish, WM; El-Kolaly, MT1
Di Santo, N; Ehrisman, J1

Reviews

1 review(s) available for nitazoxanide and Neoplasms

ArticleYear
A functional perspective of nitazoxanide as a potential anticancer drug.
    Mutation research, 2014, Volume: 768

    Topics: Animals; Antineoplastic Agents; Antiparasitic Agents; Cell Proliferation; Cell Survival; Humans; Neoplasms; Nitro Compounds; Proto-Oncogene Proteins c-myc; Signal Transduction; Stromal Cells; Thiazoles; Unfolded Protein Response

2014

Other Studies

5 other study(ies) available for nitazoxanide and Neoplasms

ArticleYear
Pathway-Based Drug Repositioning for Cancers: Computational Prediction and Experimental Validation.
    Journal of medicinal chemistry, 2018, 11-08, Volume: 61, Issue:21

    Topics: Antineoplastic Agents; Computational Biology; Drug Repositioning; Neoplasms

2018
Nitazoxanide and Cancer Drug Resistance: Targeting Wnt/β-catenin Signaling Pathway.
    Archives of medical research, 2022, Volume: 53, Issue:3

    Topics: Drug Resistance, Multiple; Drug Resistance, Neoplasm; Humans; Neoplasms; Nitro Compounds; Thiazoles; Wnt Signaling Pathway

2022
Cancer Drug Resistance Reduction via Co-treatment with Oxaliplatin and Nitazoxanide: Targeting the ABC Transporters.
    Current molecular medicine, 2023, Volume: 23, Issue:8

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Cell Line, Tumor; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Multidrug Resistance-Associated Proteins; Neoplasm Proteins; Neoplasms; Oxaliplatin

2023
The successful treatment of
    Frontiers in cellular and infection microbiology, 2022, Volume: 12

    Topics: Diarrhea; Enterocytozoon; Feces; Humans; Male; Microsporidiosis; Middle Aged; Neoplasms; Positron Emission Tomography Computed Tomography

2022
Laser-responsive liposome for selective tumor targeting of nitazoxanide nanoparticles.
    European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2018, Jan-01, Volume: 111

    Topics: Animals; Antiparasitic Agents; Lasers; Liposomes; Mice; Nanoparticles; Neoplasms; Nitro Compounds; Particle Size; Thiazoles

2018